Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yellow 560 and Fluorescein for Intracranial Lesions
NCT02478346Phase 4Unknown
- Sponsor
- AdventHealth
- Start
- May 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fluorescein in intracranial neoplasm, cerebrovascular disease, sponsored by AdventHealth. Status: unknown.
02
Drugs
fluorescein
03
Conditions
intracranial neoplasmcerebrovascular disease
Beyond the preview
Go deeper on NCT02478346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02478346.